Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Cocrystal Pharma, Inc. (COCP) had Stock-Based Compensation of $0.17M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.06M |
|
-- |
|
-- |
|
$2.11M |
|
$-2.11M |
|
$0.05M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.11M |
|
$-1.94M |
|
10.17M |
|
10.17M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$6.76M |
|
$0.11M |
|
$1.74M |
|
$8.51M |
|
$1.83M |
|
-- |
|
$1.34M |
|
$3.17M |
|
$5.33M |
|
$5.33M |
|
$5.33M |
|
10.17M |
|
| Cash Flow Statement Financials | |
$-5.09M |
|
-- |
|
-- |
|
$9.94M |
|
$4.84M |
|
$-5.09M |
|
|
Stock-Based Compensation |
$0.17M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-38.53% |
|
-38.53% |
|
-24.16% |
|
-38.53% |
|
$0.52 |
|
$-0.50 |
|
$-0.50 |
|